Cristina Ferro Teixeira

Ms. Cristina Ferro Teixeira

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2026 in Cancers
Verified
Journal Article
Open access
PDF file
CTCristina Ferro Teixeira
Cristina Ferro Teixeira
MAMehmet Orbay Orbay Askeroğlu
Mehmet Orbay Orbay Askeroğlu
MBMarlies Boussaer
Marlies Boussaer
SLSven Van Laere
Sven Van Laere
Selçuk PekerSelçuk Peker
Selçuk Peker
TGThierry Gevaert
Thierry Gevaert
Background/Objectives: LINAC-based single-isocenter (SIT) stereotactic radiosurgery (SRS) enables efficient treatment of multiple brain metastases but may compromise target conformity and increase low-dose brain exposure, particularly for spatially distributed lesions. Dual-isocenter techniques (DITs) may mitigate these limitations, while Gamma Knife (GK) remains the reference standard for high-selectivity radiosurgery. This study compares SIT- and DIT LINAC-based SRS with GK, focusing on target conformity and low-dose brain exposure under equivalent, zero-margin targeting assumptions. Methods: Twenty-eight patients with multiple brain metastases (197 lesions) were included in this retrospective planning study. For each patient, three plans were generated: a GK plan and LINAC-based SIT and DIT plans using automated dynamic conformal arc optimization (Elements Multiple Brain Metastases). All plans were generated using a zero-millimeter GTV-to-PTV margin strategy. For DIT, lesions were automatically clustered and assigned to two isocenters. Target coverage required ≥99% of each GTV to receive the prescription dose. Plan quality was evaluated using the Paddick Conformity Index (PCI) on a per-lesion basis and low-dose brain volumes (V12, V10, V5, V4, and V3 Gy) on a per-patient basis. Paired non-parametric tests and multivariable models were used to assess technique-related differences and associations with total target volume and lesion count. Results: GK achieved the highest median PCI (0.83), followed closely by DIT (0.77), while SIT plans demonstrated significantly lower conformity (0.73). Compared with GK, the median PCI difference was −0.05 for DIT and −0.08 for SIT. Conformity for DIT remained stable across lesion volumes and lesion counts, whereas GK conformity increased modestly with lesion size. Low-dose brain exposure differed significantly between techniques at all dose levels (p < 0.001). GK consistently yielded the lowest Vx volumes, SIT the highest, and DIT intermediate values. Relative to GK, SIT plans showed progressively larger increases in low-dose exposure at lower dose levels (mean ΔV3 ≈ +149 cc), while DIT reduced this low-dose spread (mean ΔV3 ≈ +117 cc). Total target volume was the dominant predictor of low-dose brain exposure across all techniques, with a smaller additional contribution from lesion count. Conclusions: DIT LINAC-based SRS significantly improves target conformity and reduces low-dose brain exposure compared with SIT delivery, achieving dosimetric performance that closely approximates Gamma Knife under equivalent zero-margin targeting assumptions. While Gamma Knife remains the reference standard for low-dose sparing, dual-isocenter planning represents a clinically robust and scalable alternative that effectively balances plan quality and treatment efficiency in patients with multiple brain metastases.

20 January 2026 in Cancers
Verified
Journal Article
Open access
PDF file
MBMarlies Boussaer
Marlies Boussaer
CTCristina Ferro Teixeira
Cristina Ferro Teixeira
KBKajetan Berlinger
Kajetan Berlinger
SMSelma Ben Mustapha
Selma Ben Mustapha
ABAnne-Sophie Bom
Anne-Sophie Bom
TGThierry Gevaert
Thierry Gevaert
Background/Objectives: Despite significant advances in imaging technology, real-time intra-fraction monitoring of moving targets remains a challenge in markerless radiotherapy. This retrospective study investigates the use of ExacTrac Dynamic by Brainlab as an intra-fraction monitoring tool for stereotactic body radiotherapy (SBRT) in both early-stage NSCLC and oligometastatic disease. Methods: A total of 63 X-ray pairs from 21 patients were analyzed to evaluate tumor visualization with and without a surrogate approach. Statistical analysis was conducted to determine whether failures could be attributed to tumor size or localization using the Mann–Whitney U-test and Fisher’s exact test. The accuracy of the X-ray/digitally reconstructed radiograph (DRR) surrogate-based fusion was assessed by calculating and comparing the corresponding 3D vectors according to the linear mixed effects model, with a random slope effect for size of surrogate and a random intercept per patient. Results: Surrogates enhanced tumor visualization on X-ray/DRR fusions from 14.3% to 75.5%. Tumor size and lung affected (left or right) did not predict visualization success. Tumor location, however, tended to influence visibility, with lesions in the upper lobes being more readily visualized (88%) than those in the lower lobes (48.1%), although no statistical significance was reported (p > 0.05). Regarding geometric accuracy, 76% of the analyzed data points deviated less than 5 mm in the 3D vector measurements, the mean values were around 4 mm (±3 mm), and the medians were within 3 mm across all conditions. No statistically significant differences (p > 0.05) were found based on the surrogate size or the triggering time of the X-ray during the breathing cycle. Conclusions: Surrogate-based DRRs, referred to as Correlation Objects, demonstrate consistent geometric accuracy across multiple surrogate sizes and X-ray acquisitions, supporting the clinical translation of markerless lung targeting workflows for lung SBRT.